- Home
- EVV vs BLFS Comparison
EVV vs BLFS Comparison
Compare EVV & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVV | BLFS |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2003 | 2013 |
Fundamental Metrics
Financial Performance| Metric | EVV | BLFS |
|---|---|---|
| Price | $9.39 | $18.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 342.5K | ★ 466.3K |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | N/A | $19.20 |
| Revenue Next Year | N/A | $18.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $8.81 | $17.98 |
| 52 Week High | $10.41 | $29.57 |
Technical Indicators
Market Signals| Indicator | EVV | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 19.95 | 30.46 |
| Support Level | N/A | N/A |
| Resistance Level | $10.19 | $25.95 |
| Average True Range (ATR) | 0.07 | 1.02 |
| MACD | -0.04 | -0.33 |
| Stochastic Oscillator | 2.70 | 5.95 |
Price Performance
Historical ComparisonAbout EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest
Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.